Sign up for upcoming conferences in the PROGRAMS section! | Dry Eye Rescue Is Offering Friends Of MDA A 20% Discount On All Products To Help With Your Eye Conditions

Click Here To Save Now

Resources

Dec 15, 2025

Regeneron Pharmaceuticals is currently sponsoring a clinical trial enrolling patients with geographic atrophy (GA) who qualif

Regeneron has partnered with The Foundation Fighting Blindness to raise awareness about an ongoing clinical trial investigating subcutaneously administered investigational

Regeneron Pharmaceuticals is currently sponsoring a clinical trial enrolling patients with geographic atrophy (GA) who qualif

Dec 9, 2025

ONL Therapeutics reports positive phase 1b data for xelafaslatide in geographic atrophy

Author(s): Martin David Harp Key Takeaways Xelafaslatide, a Fas inhibitor, shows promise in protecting retinal cells and slowing GA progression

ONL Therapeutics reports positive phase 1b data for xelafaslatide in geographic atrophy

Dec 9, 2025

Supporting eye health through a holistic approach to full-body health

Author(s):Vittorio Mena, OD, MS, Fact checked by: Matt Hoffman, Kirsty Mackay Our patients benefit from a preventive approach that includes lifestyle adjustment,

Supporting eye health through a holistic approach to full-body health

Dec 9, 2025

Majority of US patients with dry eye experience symptoms weekly, survey finds

Author(s): Jordana Joy, Associate Editor Fact checked by: Ron Panarotti The survey was conducted by OnePoll on October 2025 and included

Majority of US patients with dry eye experience symptoms weekly, survey finds

Dec 3, 2025

Thank you-#GivingTuesday

Thank you to all who participated in yesterday’s # GivingTuesday. Your support fuels vital research and inspires hope for a

Thank you-#GivingTuesday

Dec 1, 2025

Judi Dench Says She ‘Can’t Recognize Anybody’ Due to Eye Condition: ‘I Can’t See Anymore’

by: Jack Dunn Judi Dench recently shared that she “can’t recognize anybody” due to her eye condition. When asked by ITV why she’s

Judi Dench Says She ‘Can’t Recognize Anybody’ Due to Eye Condition: ‘I Can’t See Anymore’

Dec 1, 2025

#GivingTuesday 2025

Join us for #GivingTuesday2025 on Tuesday, December 2nd, from 12:00 AM to 11:59 PM! Your generous support can make a

#GivingTuesday 2025

Nov 26, 2025

Happy Thanksgiving

Happy Thanksgiving! The Macular Degeneration Association would like to express our gratitude for your support and thoughtfulness. “As we show

Happy Thanksgiving

Nov 26, 2025

Low Vision vs Legally Blind: What’s the difference?

Dr. Long, thank you for explaining the difference between low vision and legal blindness. Low vision vs. legally blind—what’s the

Low Vision vs Legally Blind: What’s the difference?

Nov 25, 2025

New Stem Cell Therapy Trial Offers Hope for Millions Living with Untreatable Advanced Dry Macular Degeneration

The research team is now monitoring 12 more participants who received higher doses of 150,000 and 250,000 cells. If no

New Stem Cell Therapy Trial Offers Hope for Millions Living with Untreatable Advanced Dry Macular Degeneration

Nov 25, 2025

FDA approves Eylea HD for macular edema after retinal vein occlusion

By: Anthony DeFino Fact checked by: Nancy Hemphill, ELS, FAAO Key takeaways: The decision is supported by positive visual acuity

FDA approves Eylea HD for macular edema after retinal vein occlusion

Nov 24, 2025

GLP-1s may double risk for development of wet AMD

By Justin Cooper Fact checked by; Christine Klimanskis, ELS Key takeaways: Patients with diabetes taking GLP-1s had a twofold higher

GLP-1s may double risk for development of wet AMD

Nov 24, 2025

EYE on MACULAR CAROTENOIDS: Diet & Supplementation

You’ve heard of Vitamin A for your eyes… but did you know there’s a family of natural pigments that may

EYE on MACULAR CAROTENOIDS: Diet & Supplementation

Nov 21, 2025

8 Foods That Fight Inflammation Even Better Than Ginger

By Anna Giorgi  Published on November 18, 2025  Medically reviewed by Karina Tolentino, RD Ginger is one of several foods that may

8 Foods That Fight Inflammation Even Better Than Ginger

Nov 18, 2025

Enjoying the Winter Wonderland: A Winter Eyecare Guide

  As winter sets in, many of us may experience symptoms that differ from those in other times of the

Enjoying the Winter Wonderland: A Winter Eyecare Guide

Nov 18, 2025

Apellis announces 5-year GALE study data in GA

Author(s): Kassi Filkins Fact checked by: Kirsty Mackay Key Takeaways SYFOVRE (pegcetacoplan injection) delays GA lesion growth by approximately 1.5 years

Apellis announces 5-year GALE study data in GA

Nov 17, 2025

The Eye Q Podcast Episode 49

In this episode of The Eye-Q Podcast, Dr. Rani Banik sits down with Dr. Debbie Ozment—an integrative dentist with over

The Eye Q Podcast Episode 49

Nov 11, 2025

Happy Veterans Day

Happy Veterans Day. Thank you to all who serve and their families for their sacrifices. “As we express our gratitude,

Happy Veterans Day

Nov 7, 2025

eSight Go headset ‘gives you your central perception back’

By: Justin Cooper Fact checked by: Christine Klimanskis, ELS Key takeaways: eSight Go uses two OLED screens to boost visual

eSight Go headset ‘gives you your central perception back’

Nov 6, 2025

GLP-1s may double risk for development of wet AMD

By: Justin Cooper Fact checked by: Christine Klimanskis, ELS Key takeaways: Patients with diabetes taking GLP-1s had a twofold higher

GLP-1s may double risk for development of wet AMD

Nov 5, 2025

Smart eye wear ‘definitely having a moment’ with jump in consumer awareness

By: Justin Cooper Fact checked by: Christine Klimanskis, ELS Key takeaways: Consumers are more familiar with smart eye wear than

Smart eye wear ‘definitely having a moment’ with jump in consumer awareness

Nov 4, 2025

Ocular Therapeutix reaches target enrollment of 555 patients in SOL-R trial

Author(s) : Martin David Harp Key Takeaways AXPAXLI is a bioresorbable hydrogel incorporating axitinib, targeting wet AMD and other retinal diseases

Ocular Therapeutix reaches target enrollment of 555 patients in SOL-R trial

Oct 30, 2025

Research supports that iron dysregulation may drive AMD

Author(s): Sydney M Crago Key Takeaways Iron dysregulation contributes to oxidative stress, inflammation, and ferroptosis, driving retinal degeneration in dry

Research supports that iron dysregulation may drive AMD

Oct 24, 2025

Starting from scratch on neovascular age-related macular degeneration

Author(s): Lynda Charters Key Takeaways Gene therapy for nAMD offers potential to reduce treatment burden and improve vision, but long-term

Starting from scratch on neovascular age-related macular degeneration

Oct 16, 2025

Consumer technology has limitations for assistive needs

By: Roland Mattern Fact checked by: Christine Klimanskis, ELS Key takeaways: Accessibility features in mainstream technology are not as reliable

Consumer technology has limitations for assistive needs

Oct 10, 2025

Sharper vision starts here

Sharper vision starts here Author(s)Jack M. Chapman, MD Fact checked by: Sheryl Stevenson Key Takeaways Over 75% of cataract patients have

Sharper vision starts here

Oct 10, 2025

Seeing Stars: Gould & Steele interview

Permission was given by Martha Steele & Ellen Gould to share this podcast.

Seeing Stars: Gould & Steele interview

Oct 8, 2025

What the eyes reveal: Cardiovascular clues in women—hidden in plain sight

Publication|Articles|October 6, 2025 Optometry Times Journal September/October digital edition 2025- Volume 17 –  Issue 05 Author(s)Lynda Charters Fact checked by: Karen S.

What the eyes reveal: Cardiovascular clues in women—hidden in plain sight

Sep 26, 2025

Seeing Through the Fog: Understanding Macular Degeneration

Helping with reading, driving, and daily tasks, caregivers often serve as the ‘eyes’ for their loved ones By: Paul Wynn,AARP

Seeing Through the Fog: Understanding Macular Degeneration

Sep 23, 2025

New eyedrop raises hopes for less invasive treatment of serious vision conditions

A new eyedrop has shown early success in delivering protective compounds to where they’re needed most in the eye, raising

New eyedrop raises hopes for less invasive treatment of serious vision conditions

Newsletter Sign-up

  • This field is for validation purposes and should be left unchanged.